Results 151 to 160 of about 79,407 (254)

Long-Term Real-World Outcomes of Tenofovir Alafenamide in Chronic Hepatitis B: Detailed Analysis of Treatment-Naive and Experienced Patients

The Korean Journal of Gastroenterology
Background/Aims: This study assessed the long-term efficacy and safety of tenofovir alafenamide (TAF) in real-world settings. Methods: Patients who were candidates for TAF treatment and were followed up at 12-week intervals over 192 weeks were enrolled ...
Yu-Xuan Song, Guang-Jun Song, Hui Ma, Bo Feng, Yan-Di Xie   +4 more
doaj   +1 more source

Brief Report: Breast Milk Transfer and Infant Exposures to Dolutegravir, Tenofovir, and Tenofovir Alafenamide: Results From IMPAACT 2010/VESTED. [PDF]

J Acquir Immune Defic Syndr
Nguyen T, Chae JW, Ziemba L, Coletti A, Knowles K, Johnston B, Jean-Philippe P, Mhembere T, Chawana T, Wabwire D, Korutaro V, Moyo S, Mandima P, Sibisi S, Violari A, Hanley S, Mmbaga B, Masheto G, Ponatshego P, Theron G, Naik SN, Shapiro R, Lockman S, Chinula L, Momper JD, IMPAACT 2010/VESTED Protocol Team.   +25 more
europepmc   +1 more source

The Role of Prior HBV Infection on the Efficacy of 3TC/DTG as a Maintenance Therapy. [PDF]

Viruses
Matucci T, Occhineri S, Palomba A, Vatteroni ML, Del Bono L, Polidori M, Iapoce R, Borghetti A, Falcone M.   +8 more
europepmc   +1 more source

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, rando

The Lancet, 2021
S. Lockman, S. Brummel, L. Ziemba, L. Stranix-Chibanda, K. McCarthy, A. Coletti, P. Jean‐Philippe, Benjamin Johnston, Chelsea Krotje, L. Fairlie, R. Hoffman, P. Sax, S. Moyo, N. Chakhtoura, J. Stringer, G. Masheto, Violet Korutaro, H. Cassim, B. Mmbaga, E. Joao, S. Hanley, Lynette Purdue, Lewis B Holmes, J. Momper, R. Shapiro, Navdeep K. Thoofer, J. Rooney, L. Frenkel, K. R. Amico, L. Chinula, J. Currier, B. Best, Cheryl Blanchette, R. Browning, Yao Cheng, Andee Fox, Nagawa Jaliaah, Kevin C Knowles, M. Mirochnick, W. Murtaugh, Emmanuel Patras, Mauricio Pinilla, J. Wyk, F. Whalen   +43 more
semanticscholar   +1 more source

Correction: Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trial. [PDF]

PLoS One
Sequera-Arquelladas S, Vivancos MJ, Vinuesa D, Collado A, Santos IL, Sorni P, Cabello-Clotet N, Montero M, Font CR, Terron A, Galindo MJ, Martinez O, Ryan P, Omar-Mohamed M, Albendín-Iglesias H, Javier R, Romero A, Vallecillos CG, Calleja MÁ, Hidalgo-Tenorio C.   +19 more
europepmc   +1 more source

Resistance Analyses of Lenacapavir, Emtricitabine/Tenofovir Alafenamide and Emtricitabine/Tenofovir Disoproxil Fumarate in the PURPOSE 1 and 2 Studies. [PDF]

J Infect Dis
Cox S, Andreatta K, Hendricks MR, Li J, Kintu A, Brown LB, Carter CC, Callebaut C.   +7 more
europepmc   +1 more source

Dapagliflozin treatment ameliorates oxidative stress, apoptosis and inflammation in tenofovir-induced nephrotoxicity in rats. [PDF]

Sci Rep
Dos Santos VA, Viotto ACR, Nascimento MM, Bernardo DRD, Shimizu MHM, de Sena CR, Seguro AC, Volpini RA, de Bragança AC, Canale D.   +9 more
europepmc   +1 more source

Switch to Fixed Dose of Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate Versus Bictegravir, Emtricitabine, and Tenofovir Alafenamide Fumarate in Virologically Suppressed Adults on Efavirenz-Based Regimens: 48-Week Results of a Real-world, Prospective, Observational Cohort Study. [PDF]

Open Forum Infect Dis
Li A, Li Z, Li J, Gao Y, Dai L, Liu A, Zhang H, Wang X, Wu L, Yao Y, Liu L, Ye J, Sun L.   +12 more
europepmc   +1 more source

Tenofovir vs. entecavir in chronic hepatitis B: A retrospective cohort study of hepatocellular carcinoma risk in a tertiary hospital in southern Brazil. [PDF]

Braz J Infect Dis
Stamm AN, Tovo CV, Noal A, Silva CU, Pizzi J, Fonseca PM, Kliemann DA.   +6 more
europepmc   +1 more source

Development of a Semi-Mechanistic Population Pharmacokinetic Model for Predicting Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Exposure in Plasma and Cellular Matrices During Pregnancy and Postpartum. [PDF]

Clin Pharmacokinet
Yu Y, Brooks KM, Doncel GF, Best BM, Marzinke MA, Mirochnick M, Anderson P, Myer L, Celum C, Heffron R, Coleman J, Davey DJ, Hendrix CW, Momper JD, Bies R, Scott RK.   +15 more
europepmc   +1 more source